I made a comment about this the other day. Very possible. Lympro is about to launch and generate revenue via ICON. This will raise the price for sure and stabilize it. I think there is a possibility with near term P2b Eltoprazine and ODD's for MANF that partners or business development opportunities could be realized very soon. They have a lot of high paid people on the payroll now, so I think they expect money beyond Lympro revenue.